Rothschild Investment LLC Axsome Therapeutics, Inc. Transaction History
Rothschild Investment LLC
- $1.49 Trillion
- Q1 2025
A detailed history of Rothschild Investment LLC transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, Rothschild Investment LLC holds 60 shares of AXSM stock, worth $6,989. This represents 0.0% of its overall portfolio holdings.
Number of Shares
60
Previous 35
71.43%
Holding current value
$6,989
Previous $2.96 Million
136.34%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding AXSM
# of Institutions
376Shares Held
37.2MCall Options Held
1.75MPut Options Held
1.18M-
Rtw Investments, LP New York, NY4.05MShares$472 Million5.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.9MShares$455 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.3MShares$384 Million0.01% of portfolio
-
Fairmount Funds Management LLC Philadelphia, PA1.47MShares$171 Million24.98% of portfolio
-
Bvf Inc San Francisco, CA1.39MShares$162 Million4.4% of portfolio
About Axsome Therapeutics, Inc.
- Ticker AXSM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 42,878,000
- Market Cap $4.99B
- Description
- Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...